Bard Associates Inc Neuroone Medical Technologies Corp Transaction History
Bard Associates Inc
- $327 Million
- Q3 2025
A detailed history of Bard Associates Inc transactions in Neuroone Medical Technologies Corp stock. As of the latest transaction made, Bard Associates Inc holds 1,851,000 shares of NMTC stock, worth $1.28 Million. This represents 0.5% of its overall portfolio holdings.
Number of Shares
1,851,000
Previous 1,854,600
0.19%
Holding current value
$1.28 Million
Previous $1.26 Million
30.61%
% of portfolio
0.5%
Previous 0.47%
Shares
2 transactions
Others Institutions Holding NMTC
# of Institutions
37Shares Held
14.4MCall Options Held
65.2KPut Options Held
0-
Bleichroeder LP New York, NY4MShares$2.76 Million0.95% of portfolio
-
Sio Capital Management, LLC New York, NY2.36MShares$1.63 Million0.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.58MShares$1.09 Million0.0% of portfolio
-
Perkins Capital Management Inc1.47MShares$1.01 Million1.29% of portfolio
-
Awm Investment Company, Inc. New York, NY917KShares$632,5000.1% of portfolio
About NEUROONE MEDICAL TECHNOLOGIES Corp
- Ticker NMTC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 16,209,200
- Market Cap $11.2M
- Description
- NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for pat...